| | 英文名称 | | 中文名称 | | CAS |
|---|---|---|
| Naxitamab | NAXITAMAB (那昔妥单抗 ) | 1879925-92-4 |
| Balstilimab | BALSTILIMAB (巴替利单抗 ) | 2230167-06-1 |
| Plamotamab | PLAMOTAMAB (帕拉莫妥单抗 ) | 2138442-31-4 |
| Tenatumomab | TENATUMOMAB ( 替妥莫单抗 ) | 1412891-40-7 |
| Urtoxazumab | URTOXAZUMAB ( 乌珠单抗 ) | 502496-16-4 |
| Cixutumumab | CIXUTUMUMAB ( 西妥木单抗 ) | 947687-12-9 |
| Rilotumumab | RILOTUMUMAB ( 利妥木单抗 ) | 872514-65-3 |
| Mavrilimumab | 玛弗利木单抗 | 1085337-57-0 |
| Olokizumab | OLOKIZUMAB ( 奥洛组单抗 ) | 1007223-17-7 |
| Ublituximab | UBLITUXIMAB ( 乌妥昔单抗 ) | 1174014-05-1 |
| Narnatumab | Narnatumab | 1188275-92-4 |
| Demcizumab | Demcizumab | 1243262-17-0 |
| Imgatuzumab | Imgatuzumab | 959963-46-3 |
| Ozanezumab | Ozanezumab | 1310680-64-8 |
| Dapirolizumab Pegol | Dapirolizumab Pegol | 1416147-64-2 |
| Coltuximab Ravtansine | Coltuximab Ravtansine | 1269764-99-9 |
| Lokivetmab | Lokivetmab | 1533403-95-0 |
| Istiratumab | Istiratumab | 1509928-04-4 |
| Pamrevlumab | Pamrevlumab | 946415-13-0 |
| Rinucumab | Rinucumab | 1569263-06-4 |
